Shanmuga Hospital Limited has announced the commissioning of a Litho Evo Laser Machine at its hospital facility, marking another step in the company's ongoing efforts to enhance its medical infrastructure and treatment capabilities.

Equipment Acquisition Details

The hospital has successfully purchased and commissioned the advanced laser equipment as part of its strategic initiative to strengthen medical services. The acquisition represents a focused investment in expanding the facility's technological capabilities.

Strategic Benefits and Applications

The Litho Evo Laser Machine is specifically designed to enhance the hospital's capabilities in urology and minimally invasive procedures. This advanced equipment is expected to deliver significant improvements in patient care and operational performance.

Key anticipated benefits include:

• Enhanced treatment capabilities in urological procedures
• Improved patient outcomes through advanced laser technology
• Increased operational efficiency in medical procedures
• Strengthened position in minimally invasive treatment options

Financial and Regulatory Aspects

Shanmuga Hospital Limited has confirmed that the equipment purchase was conducted in the ordinary course of business operations. The company has clarified that this acquisition does not constitute a related party transaction and will not have a material impact on the organization's financial position.

Infrastructure Enhancement Initiative

This latest acquisition aligns with Shanmuga Hospital Limited's continuous commitment to upgrading its medical infrastructure. The addition of the Litho Evo Laser Machine represents the hospital's dedication to providing advanced healthcare solutions and maintaining competitive treatment capabilities in specialized medical areas.

Shanmuga Hospital Limited, formerly known as Shanmuga Hospital Private Limited, has announced its unaudited financial results for the half-year ended September 30, 2025. The company, which operates in the hospital and healthcare services sector, has reported a net profit of ₹201.13 crore for the period.

Financial Highlights

Key Financial Metrics

The company's performance shows a mixed picture when compared to previous periods:

• Net profit of ₹201.13 crore, up from ₹181.38 crore in the previous period
• However, net profit is down from ₹239.29 crore in the corresponding period last year
• Total expenses stood at ₹2,201.68 crore
• Cost of consumption was the largest expense at ₹813.05 crore
• Other expenses amounted to ₹828.12 crore
• Employee benefits expense was ₹366.76 crore

IPO Proceeds Utilization

Shanmuga Hospital Limited completed the full utilization of its IPO proceeds of ₹2,061.72 crore during the reporting period. The funds were allocated as follows:

The company reported that the opening unutilized IPO proceeds of ₹1,115.50 crore as of April 1, 2025, were fully utilized during the first half of the year (April 2025 to September 2025) towards the object of the issue.

Balance Sheet Overview

As of September 30, 2025, Shanmuga Hospital Limited's balance sheet shows:

The Board of Directors approved these results at their meeting held on November 12, 2025. The company operates only in one business segment – Hospital and Healthcare Services.

Shanmuga Hospital Limited continues to focus on its core operations in the healthcare sector, with its financial results reflecting the ongoing challenges and opportunities in the industry. The company's full utilization of its IPO proceeds indicates a focus on expansion and operational improvements.